MedPath

Glycerin BP

Marketing Authorization Holder: L.C.M. Ltd Linthwaite Laboratories Huddersfield HD7 5QH England

Authorised
Legal Category

General Sales List

ATC Code

Not classified

Authorization Number

PL: 12965/0012

Summary of Product Characteristics

Detailed prescribing information and pharmaceutical guidance from the UK Electronic Medicines Compendium.

Composition

Active and inactive ingredients

Glycerol 100 % v/v

Pharmaceutical Form

Dosage form and administration route

Liquid.

Clinical Particulars

Therapeutic indications and usage

4.1 Therapeutic indications

  1. For the relief of the symptoms of sore throats.
  2. For use on rough or chapped skin.4.2 Posology and method of administration
  3. Oral: 5-10ml, four hourly as required.
  4. Topical: mix with an equal quantity of water and apply directly to the affected area up to six times daily. This product is suitable for use by adults, children and the elderly.4.3 Contraindications Contraindicated in patients with known hypersensitivity to glycerol. Contraindicated in diabetics.4.4 Special warnings and precautions for use Glycerol should be administered with caution to patients with hypervolaemia, cardiac failure, renal disease or dehydration. Labels to state: Use with caution if you suffer from heart or kidney disease.4.5 Interaction with other medicinal products and other forms of interaction None known.4.6 Pregnancy and lactation No adverse effects are considered likely if this product is used in the above conditions. However, all medicines, should be avoided if possible during pregnancy and lactation, and should only be used under a doctor's instruction.4.7 Effects on ability to drive and use machines None.4.8 Undesirable effects Glycerol when taken orally may cause headache, nausea and vomiting, and less frequently, diarrhoea, thirst, dizziness and mental confusion. Cardiac arrhythmias have been reported. Glycerol may cause severe dehydration in previously dehydrated patients. **Reporting of suspected adverse reactions** Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.4.9 Overdose Glycerol acts as a mild laxative. Large oral doses taken inadvertently may cause headache, thirst, nausea, hyperglycaemia and dehydration. Medication should be stopped and if ingestion is recent gastric lavage should be administered, followed by supportive therapy.

Pharmacological Properties

Pharmacodynamics and pharmacokinetics

5.1 Pharmacodynamic properties Glycerol acts as a demulcent and is mildly laxative when taken by mouth.5.2 Pharmacokinetic properties Glycerol is readily absorbed from the intestine and is metabolised to carbon dioxide and glycogen or is used in the synthesis of body fats.5.3 Preclinical safety data None

Pharmaceutical Particulars

Storage and handling information

6.1 List of excipients None.6.2 Incompatibilities None known.6.3 Shelf life 36 months unopened.6.4 Special precautions for storage None.6.5 Nature and contents of container 100ml: Glass bottle with white tamper evident 28mm polypropylene cap with EPE/Saranex liner and ROPP neck finish. 200ml: Glass bottle with white tamper evident 28mm polypropylene cap with EPE/Saranex liner and ROPP neck finish.6.6 Special precautions for disposal and other handling None.

Last updated: 13/04/2015

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.